Cadila Healthcare informs about unaudited financial results

02 Nov 2017 Evaluate

Pursuant to regulation 30 of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, Cadila Healthcare has informed that the Company has planned investor interaction through a conference call on November 14, 2017 at 4:00 p.m., post announcement of unaudited financial results for the quarter / half year ended on September 30, 2017.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

910.00 0.00 (0.00%)
17-Feb-2026 10:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.00
Dr. Reddys Lab 1266.55
Cipla 1347.50
Zydus Lifesciences 910.00
Lupin 2247.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×